Equities

VirTra Inc

VirTra Inc

Actions
IndustrialsAerospace and Defense
  • Price (USD)9.16
  • Today's Change0.04 / 0.44%
  • Shares traded203.11k
  • 1 Year change+17.29%
  • Beta0.5870
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

VirTra, Inc. is a provider of judgmental use of force training simulators and firearms training simulators for the law enforcement, military, and commercial markets. The Company's patented technologies, software, and scenarios provide intense training for de-escalation, judgmental use-of-force, marksmanship and related training that mimics real-world situations. Its firearms training simulator allows marksmanship and realistic scenario-based training to take place on a daily basis without the need for a shooting range, protective equipment, role players, safety officers, or a scenario-based training site. It has developed a range of simulation training including capabilities such as multiscreen, video-based scenarios, scenario authoring ability, superior training scenarios, the patented Threat-Fire shoot-back system, gas-powered simulated recoil weapons, and more. Its simulator products include V-300 Simulator, V-180 Simulator, V-100 Simulator & V-100 MIL, V-Author and others.

  • Revenue in USD (TTM)36.11m
  • Net income in USD6.67m
  • Incorporated2016
  • Employees112.00
  • Location
    VirTra Inc295 E CORPORATE PLACECHANDLER 85225United StatesUSA
  • Phone+1 (480) 968-1488
  • Websitehttps://www.virtra.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fossil Group Inc1.34bn-140.12m63.52m6.10k--0.275--0.0473-2.67-2.6725.594.361.362.468.85220,038.00-14.14-4.59-20.23-7.2448.6049.48-10.41-3.631.40-3.940.473---16.05-11.09-255.75---13.84--
BioNano Genomics Inc37.47m-226.79m64.72m344.00--0.6729--1.73-6.15-6.150.9421.440.16651.034.97108,924.40-100.76-56.82-128.31-67.8327.5425.38-605.26-505.761.13-83.420.0444--29.9024.65-75.34--38.51--
Midwest Energy Emissions Corp18.48m4.79m76.44m9.0020.639.2615.264.140.03930.03930.18940.08751.4715.1415.632,053,822.0038.13-21.6555.76-47.8133.5132.8025.92-15.572.39-7.560.278---17.027.85473.32------
Virtra Inc36.11m6.67m101.77m112.0015.112.3113.382.820.60640.60643.293.960.56460.9492.94322,418.0010.437.6912.999.7069.7359.0618.4811.122.46--0.1535--34.4216.04329.6259.3430.96--
Babcock & Wilcox Enterprises Inc965.65m-96.86m106.48m2.20k------0.1103-1.08-2.4210.82-2.491.096.715.28438,932.70-9.27-5.50-16.03-11.8722.8522.90-8.47-5.301.110.5301.90--17.86-1.22-201.13--12.36--
Luna Innovations Inc116.61m-1.12m113.42m337.00--1.2025.630.9726-0.0339-0.06373.452.790.75151.262.84346,035.60-0.72310.8556-0.92921.0959.0056.43-0.96221.231.620.13660.25210.0025.1227.05-111.20--16.38--
Seer Inc15.67m-83.00m116.89m147.00--0.3047--7.46-1.29-1.290.24455.910.0351.652.35106,625.90-18.55-16.65-19.08-17.0949.76---529.52-756.7124.81--0.00--7.54--7.20--112.67--
Geospace Technologies Corp136.33m16.02m131.75m681.008.280.92664.190.96641.191.1910.1910.640.92073.607.52200,193.8010.82-5.1011.92-5.5441.3128.7011.75-8.964.52--0.00--39.5010.45153.40--11.01--
Harvard Bioscience, Inc.106.79m-8.73m137.67m391.00--2.00--1.29-0.2029-0.20292.501.580.76621.746.46273,112.50-6.26-3.29-7.60-3.8958.5256.67-8.18-4.570.9352-0.40170.341---0.9573-1.4564.11--18.10--
Data as of May 31 2024. Currency figures normalised to VirTra Inc's reporting currency: US Dollar USD

Institutional shareholders

12.66%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 2024471.47k4.24%
Renaissance Technologies LLCas of 31 Mar 2024183.74k1.65%
Russell Investment Management LLCas of 31 Mar 2024173.39k1.56%
Geode Capital Management LLCas of 31 Mar 2024113.38k1.02%
BlackRock Fund Advisorsas of 31 Mar 2024102.68k0.92%
American Century Investment Management, Inc.as of 31 Mar 202490.77k0.82%
Dimensional Fund Advisors LPas of 31 Mar 202488.15k0.79%
Calamos Advisors LLCas of 31 Mar 202462.86k0.57%
Millennium Management LLCas of 31 Mar 202461.30k0.55%
SBAuer Funds LLCas of 31 Mar 202459.00k0.53%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.